One of the more aggressive types is triple negative breast cancer, which is diagnosed most frequently in young women and new mothers, and even more so among black and Hispanic women. Now, two North Texas doctors are making major strides in treating triple negative breast cancer. Their work is so promising, the New England Journal of Medicine is publishing a study about the investigational treatment this month, WFAA-TV reports. Research from the doctors show a drug called iniparib, also called BDI-201, has prolonged the lives of more than 50 percent of the patients who have used the treatment. Watch the entire WFAA-TV news segment here or ...
Dr. Rena Pasick, a professor at the University of California, San Francisco, spoke about mixed methods of cancer health disparities research during a recent speech that was part of the new San Antonio Life Sciences Institute (SALSI) and Cancer Therapy and Research Center (CTRC) Distinguished Health Disparities Lecture Series. Dr. Pasick, a well-established population-based cancer control researcher, conducts community- and clinic-based intervention studies to increase the use of and access to breast and cervical cancer screening among ethnically diverse and underserved communities. She also developed a training program to encourage minority students and professionals to pursue doctoral degrees in cancer research. Watch Dr. Pasick's lecture here. The lecture series, coordinated by ...
Latinas, here's a reminder to get yourself a holiday gift that can save your life—your annual mammogram, which can detect breast cancer early, when it's most treatable. Watch a true-to-life public service announcement here or below to see why, despite busy lives and a bustling holiday season, Latinas ages 40 and older should set aside time to take care of their own health and get their mammogram: This PSA is brought to you by Redes En Acción, the national Lation cancer research network, which is funded by the National Cancer Institute (NCI) and based at the Institute for Health Promotion Research at The UT Health Science Center at San Antonio. Please tell us what you ...
The Leukemia & Lymphoma Society's new bilingual booklet, Knowing All Your Treatment Options/Conozca Todas Sus Opciones de Tratamiento, aims to help patients understand clinical trials as one of the treatment choices they may want to consider. There is also a Healthcare Question Guide inside the back cover of the booklet for patients and family members to take with them to their doctor appointments. To access this booklet and others on the Leukemia & Lymphoma Society's Web site, please visit www.LLS.org/freematerials, or you can order hard copies of the booklet by calling 1-800-955-4572 between 9 a.m. and 6 p.m. EST. Information specialists can answer general questions about blood cancers and help patients form additional questions to ask their doctor specific to their ...
Are you a Latino master's student or master's-level professional in Texas? You are invited to apply by Feb. 18, 2011, for Éxito! Latino Cancer Research Leadership Training, a new training program to encourage Latino master’s students and master’s professionals to pursue a doctoral degree in a Latino health disparity research field and/or cancer control research career. Éxito! is led by the Institute for Health Promotion Research at The UT Health Science Center at San Antonio. Éxito! consists of: A 5-day Summer Institute in June 2011 that offers teaching, tools and resources
Paid Internships (Starting in 2012)
Doctoral Application Support Awards (Starting in 2012)
Doctoral Biannual Retreats (Starting in 2014) "We believe that Éxito! can increase ethnic diversity in the ...
Although screening tests are widely available, many cancers aren't diagnosed until the disease is well-advanced and, therefore, less treatable, a new U.S. government report finds, HealthDay reports. Almost one-half of colorectal cancers and cervical cancers and one-third of breast cancers in the U.S. are detected at a late stage, according to the report by the U.S. Centers for Disease Control and Prevention. The report also found that Latinas ages 50-79 have the highest rates of late-stage cervical cancer. Yet, if caught early, these three cancers have very high survival rates. "People need to be aware of what they need to have done medically and follow-up with their providers," said report co-author Dr. Lisa Richardson, associate director for science in CDC's Division of Cancer ...
Check out the latest in health disparities—from cancer awareness videos to new Latino training programs—in the latest E-newsletter from the Institute for Health Promotion Research (IHPR) at The University of Texas Health Science Center at San Antonio, which runs SaludToday. View the IHPR E-newsletter to see these items: Video: Latino cancer research network expands with $5.6M grant (Pg 1)
Story: An “Insider” Training Program for Latino Cancer Researchers (Pg 3)
PSA Wins Award: WATCH – Latinas & Mammograms (Pg 4)
Story: San Antonio Goes Smoke-Free (Pg 5)
Story: Lance Armstrong Visits Patients, Latino Cancer Researchers (Pg 8) Find much more on local and national health disparities-related news, funding, resources and events by visiting the IHPR's Web ...
"Fatalism," a belief that life's events are predetermined, may be one reason why Latinas have some of the lowest cancer screening rates in the U.S., new research suggests. Hispanic women are much more likely than white women to believe that cancer is not preventable, and that death is inevitable in those diagnosed with cancer, the researchers found in the study, scheduled for publication in the online edition of the International Journal of Behavioral Medicine. Researchers identified a statistically significant link between fatalism and reduced use of cancer screening services. Further studies are needed to learn more about this association, the authors noted. "Improving our understanding of the importance of fatalism in explaining underutilization of cancer screening services among ...
White women with private insurance waited an average of 15.9 days between breast cancer testing and confirmatory diagnosis, while privately insured black women waited 27.1 days and Latinas 51.4 days, according to a new study. The study, which involved almost 1,000 women examined for breast cancer, indicates that race/ethnicity plays a larger role than insurance in getting a timely breast cancer diagnosis. For women on Medicare or Medicaid, the wait between testing and diagnosis was 11.9 days for whites, 39.4 days for blacks and 70.8 days for Latinas. Among those without insurance, the wait was 44.5 days for whites compared with 59.7 days for blacks and 66.5 days for ...
